BackPressure BioSciences Overview
Pressure BioSciences, Inc.

Pressure BioSciences Return on Equity

Latest ROE for Pressure BioSciences: 84.23% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

84.23%

Return on Equity

84.23%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Pressure BioSciences (PBIO) FAQ

The latest ROE for PBIO is 84.23%. That is above the sector sector average of 11.3%. Investors often review this figure alongside Pressure BioSciences's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PBIO currently prints 84.23% for ROE, while the sector average sits near 11.3%. That is roughly 645.6% above the sector mean. Large gaps often invite a closer look at Pressure BioSciences's growth, margins, and balance sheet.

Return on Equity shows how effectively Pressure BioSciences converts resources into returns. At 84.23%, PBIO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PBIO's ROE (84.23%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.